IL-2 Antibody [G3L7]

Catalog No.: F6608

    Application: Reactivity:
    • Lane 1: Recombinant Human Interleukin-2
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    転写条件(ウェット): 200 mA, 60 min,Recommended to use 0.22 μm PVDF 膜の使用をお勧めします。

    使用情報

    Dilution
    1:1000
    1:100
    Application
    WB, IP
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    18 kDa
    ポジティブコントロール Jurkat cells (TPA, 40 nM, overnight; A23187, 2 μM; BFA, 300 ng/ml, 45 min delay)
    ネガティブコントロール Jurkat cells

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.22 µm PVDF membrane is recommended )Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 60 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

    Datasheet & SDS

    生物学的記述

    Specificity
    IL-2 Antibody [G3L7] detects endogenous levels of total IL-2 protein.
    タンパク質の局在
    細胞外環境
    Uniprot ID
    P60568
    Clone
    G3L7
    Synonym(s)
    aldesleukin, IL-2, IL2, interleukin 2, Interleukin-2, involved in regulation of T-cell clonal expansion, lymphokine, cell growth factor, T-cell growth factor, TCGF
    Background
    Interleukin‑2 (IL‑2) is a type I cytokine of the common γ‑chain family that is produced mainly by activated T cells and acts as a central regulator of T cell and NK cell expansion, differentiation, and survival. The protein adopts a four‑helix bundle fold typical of this cytokine family and signals through a receptor system composed of IL‑2Rα (CD25), IL‑2Rβ (CD122), and the common γ‑chain (γc, CD132), which assemble into receptors of different affinity depending on subunit composition and expression level on distinct lymphocyte subsets. IL‑2Rα binds IL‑2 with low affinity and presents the cytokine to IL‑2Rβ and γc, creating an intermediate‑ to high‑affinity signaling complex, whereas IL‑2Rβ and γc form the signaling core and are shared with other γc cytokines, with IL‑2Rβ also serving IL‑15 and γc participating in IL‑4, IL‑7, IL‑9, IL‑15, and IL‑21 receptor complexes. Engagement of IL‑2 with IL‑2Rβ and γc brings together the associated tyrosine kinases JAK1 and JAK3, induces their activation, and leads to phosphorylation of receptor cytoplasmic tails that recruit and activate STAT5, which dimerizes and translocates to the nucleus to drive transcription of IL‑2‑responsive genes. IL‑2 also connects to PI3K–Akt and MAPK pathways through docking of signaling intermediates on phosphorylated receptor motifs, generating additional outputs that influence metabolic activity, cell cycle progression, and survival in IL‑2‑responsive lymphocytes. Within CD4⁺ T cell populations, IL‑2–STAT5 signaling supports effector T cell proliferation and function and at the same time sustains regulatory T cell development, maintenance, and suppressive capacity, with Treg cells expressing high‑affinity IL‑2 receptors and depending on IL‑2 produced by conventional T cells. IL‑2 signaling contributes to activation‑induced cell death by promoting expression of death pathway components in expanded T cells and thereby participates in contraction of T cell responses after antigen clearance. Persistent or altered IL‑2 pathway activity associates with immune dysregulation, including autoimmunity when IL‑2 availability or IL‑2R signaling to Treg cells is reduced, and with impaired pathogen control or antitumor responses when effector IL‑2 responses are limited.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください